Methylin chewable ADHD drug

ADHD :: Methylin chewable ADHD drug

U.S. regulators have approved the first chewable tablet medication for Attention Deficit Hyperactivity Disorder.

The Food and Drug Administration approved Alliant's Methylin Chewable Tablets and Methylin Oral Solution and the pediatric specialty pharmaceutical company said the goal is to increase compliance.

Dr. Lyndon Waugh of Emory University said children often have difficulty swallowing pills so the new offerings could help ensure they take their medication. It's estimated up to 26 percent of the general population has difficulty swallowing tablets and capsules and the percentage is considered higher for children.

ADHD is a brain disorder that causes children to exhibit inappropriate impulsivity or inattention. It is estimated that 7 percent of school-age children and 4 percent of adults suffer from ADHD, one of the most commonly reported behavioral problems.